Found out that the lead researcher (Robert Benezra PhD) for AGGX, and a board member there is also now a shareholder. Since they're dark it's unknown whether he purchased them or was awarded them when he became a director (probably the latter). Or how many shares he has. Still, a significant development, along with their announcement that Memorial Sloan Kettering is also a shareholder. I wonder how many other "dark" OTC companies MSK invests in :)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.